Niagen Bioscience Inc (NAGE) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Niagen Bioscience Inc   (NASDAQ: NAGE)


Niagen Bioscience Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Niagen Bioscience Inc's ROI in the third quarter of 2026?
Niagen Bioscience Inc achieved a return on average invested assets (ROI) of 11.34 % in its third quarter of 2026, this is above NAGE's average return on investment of -57.32%.
Niagen Bioscience Inc invested over the 12 months ending in its third quarter of 2026 $90 million

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Consumer Non Cyclical sector 3 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 258, from total ROI ranking in the second quarter of 2026 at 273.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 41.44 % 57.62 % 73.62 % 82.32 % 77.45 %
Y / Y Net Income Change TTM -49.88 % -9.8 % 31.99 % 91.92 % 987.81 %
Investment (TTM) in Millions 92 92 92 86 75
Return On Investment (TTM) 11.34 % 18.54 % 23.11 % 23.84 % 31.99 %
NAGE's Overall Ranking # 258 # 273 # 177 # 165 # 183
Seq. Investment Change TTM 4.74 % 6.92 % 10.63 % 14.15 % 16.73 %
Seq. Net Income Change TTM -35.96 % -14.2 % 7.22 % -14.92 % 15.23 %
Net Income (TTM) in Millions 10 16 19 17 20

NAGE Company Profile >> Back to NAGE Roi Comparisons >> See Annual NAGE Return On Investment



Return On Investment NAGE's Ranking
Within: No.
Industry # 0
Sector # 4
Overall # 258

Return On Investment Statistics
High Average Low
31.2 %
-57.32 %
-216.45 %
(Jun 30 2025)   (Sep 29 2012)







Financial Statements
Niagen Bioscience Inc's III. Quarter Investments $ 92 Millions NAGE's Balance sheet
Niagen Bioscience Inc's III. Quarter Income $ -1 Millions Quarterly NAGE's Income Statement
NAGE's Income by Division See NAGE's Income by Division


NAGE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 86 50 34 36 40
Y / Y Investment Growth 71.84 % 46.56 % -5.1 % -10.04 % 83.84 %
Net Income in Millions 17 9 -5 -17 -27
Y / Y Net Income Growth 103.3 % - - - -
Annual Return On Investment 20.1 % 16.99 % -14.38 % -45.71 % -67.44 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 20.1 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Legal Cannabis Industry Roi Trends and Statistics
Consumer Non Cyclical Sector Return On Investment Statistics
Roi Trends for overall market
NAGE's Roi Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NAGE's Competitors
Subscribers only: Roi for Niagen Bioscience Inc's Suppliers
Subscribers only: Return On Investment for NAGE's Customers

Other Ratios
NAGE's Roa NAGE's Inventory Turnover Ratio NAGE's Growth Rates NAGE's Dividend Statistics
NAGE's Profitability Ratios NAGE's Asset Turnover Ratio NAGE's Dividend Growth
NAGE's Roe NAGE's Valuation Ratios NAGE's Financial Strength Ratios NAGE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Consumer Non Cyclical Sector ROI
The Vita Coco Company Inc   28.37 %
Altria Group Inc   26.82 %
Axil Brands Inc   22.23 %
Colgate palmolive Company  20.06 %
Procter and Gamble Co  17.47 %
Hershey Co  16.71 %
The Clorox Company  15.07 %
Coca Cola Co  14.46 %
The Marzetti Company  14.05 %
Pepsico Inc   13.66 %
Philip Morris International Inc   12.51 %
Ennis Inc   12.17 %
Mccormick and Company Incorporated  11.21 %
Sanfilippo John B and Son Inc  11.15 %
Constellation Brands Inc   10.37 %
Church and Dwight Co Inc   9.23 %
Cvr Partners Lp  9.06 %
Smithfield Foods Inc   8.69 %
Seaboard Corporation  7.81 %
Mondel z International Inc   7.76 %
Ecolab Inc   7.61 %
Archer daniels midland Co  7.51 %
Kenvue Inc   7.16 %
Molson Coors Beverage Company  4.67 %
Pilgrim s Pride Corporation  4.00 %
Bunge Global Sa  3.82 %
Educational Development Corporation  3.81 %
Lamb Weston Holdings Inc   3.65 %
Fresh Del Monte Produce Inc  2.80 %
Est e Lauder Companies Inc  2.63 %

Date modified: 2026-11-06T12:57:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.